|
| |
| | | 56312 | | 09.08.2004 | | AbbVie AG | | 06.11.2007 | | | | | | | | | | | 07.05.20. | | | | 07.05. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Zemplar 5 ug/1ml | Injektionslösung | Solution injectable (Paricalcitol 5 µg/ml) | H05BX02 | | | 02 | Zemplar 10 ug/2ml | Injektionslösung | Solution injectable (Paricalcitol 10µg / 2ml) | H05BX02 | | | 03 | Zemplar 2 ug/1ml | Injektionslösung | Solution injectable (Paricalcitol 2 µg/ml) | H05BX02 | |
|
|
|
